As of 2026, DSIP is not approved by any regulatory authority (FDA, EMA, ANSM)

Metabolism & Elimination The metabolic fate of KLOW Blend involves parallel processing of four distinct peptides [20]: BPC-157: Plasma half-life under 30 minutes but biological effects persist for hours to days TB-500: Estimated 2-3 hour half-life with C-terminal degradation patterns GHK-Cu: Estimated 2-4 hour half-life involving copper release and peptide fragmentation KPV: Estimated 1-2 hour half-life with rapid peptidase degradation to amino acids Complex interactions between components may influence individual clearance rates All components metabolize to amino acids that enter normal metabolic pathways A significant pharmacokinetic paradox exists across all components: despite rapid plasma clearance (30 minutes to 4 hours), biological effects often persist well beyond plasma elimination, suggesting tissue retention, active metabolite formation, persistent signaling cascade activation, or gene expression changes that outlast peptide presence

The same studies can be located independently on PubMed using the CAS number (89030-95-5 (GHK-Cu complex)
Topical wolverine stack application would likely provide only superficial wound healing benefits at the application site without the broader systemic effects that make this stack valuable
Before you leave, well schedule follow-up appointments and answer any questions about your treatment plan